NCT07518329 Study of ALA-101 in Patients With CD19 Positive Non-Hodgkin Lymphoma and Leukemia. Status NOT_YET_RECRUITING Phase PHASE1
NCT07410676 EBNK-001 Allogeneic NK Cells With Low-Dose IL-15 ± Pembrolizumab in Advanced Solid Tumors Status RECRUITING Phase PHASE1/PHASE2
NCT07305337 Randomised Controlled Trial of Artificial Intelligence-assisted Health Education Status RECRUITING Phase NA
NCT07296445 A Trial to Investigate Whether Oral Arsenic Trioxide Is Similar to Intravenous Arsenic Trioxide in Pharmacokinetics, Safety, and Efficacy (LATITUDE/SDKARS-301) Status NOT_YET_RECRUITING Phase PHASE3
NCT05473325 Benchtop NMR Spectroscopy for Assessment of Clinical Human Pathologies (BRANCH-P STUDY) Status UNKNOWN Phase N/A
NCT03594955 First in Human Testing of Dose-escalation of SAR440234 in Patients With Acute Myeloid Leukemia, Acute Lymphoid Leukemia and Myelodysplastic Syndrome Status TERMINATED Phase PHASE1/PHASE2
NCT02310997 Myloablative Cord Blood Transplant in Haematological Malignancies (MAC UCBT) Status TERMINATED Phase PHASE2
NCT01941680 High Risk Adult T-cell Leukemia/Lymphoma (ATLL-HR) and Allogeneic Transplant Status COMPLETED Phase N/A
NCT01313689 Ofatumumab vs Physician's Choice in Subjects With Bulky Fludarabine-Refractory Chronic Lymphocytic Leukemia Status COMPLETED Phase PHASE3
NCT00502385 Phase I AZD2171 in Patients With Relapsed or Refractory AML and Elderly Patients With DeNovo or Secondary AML Status COMPLETED Phase PHASE1